Cargando…
Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders
Six halogenated trimethoxy chalcone derivatives (CH1–CH6) were synthesized and spectrally characterized. The compounds were further evaluated for their inhibitory potential against monoamine oxidases (MAOs) and β-secretase (BACE-1). Six compounds inhibited MAO-B more effectively than MAO-A, and the...
Autores principales: | Koyiparambath, Vishal Payyalot, Oh, Jong Min, Khames, Ahmed, Abdelgawad, Mohamed A., Nair, Aathira Sujathan, Nath, Lekshmi R., Gambacorta, Nicola, Ciriaco, Fulvio, Nicolotti, Orazio, Kim, Hoon, Mathew, Bijo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226672/ https://www.ncbi.nlm.nih.gov/pubmed/34201128 http://dx.doi.org/10.3390/pharmaceutics13060850 |
Ejemplares similares
-
Halogenated Coumarin–Chalcones as Multifunctional
Monoamine Oxidase-B and Butyrylcholinesterase Inhibitors
por: Rehuman, Nisha Abdul, et al.
Publicado: (2021) -
Navigating into the Chemical Space of Monoamine Oxidase
Inhibitors by Artificial Intelligence and Cheminformatics Approach
por: Kumar, Sunil, et al.
Publicado: (2021) -
Structural Modifications on Chalcone Framework for Developing New Class of Cholinesterase Inhibitors
por: George, Ginson, et al.
Publicado: (2022) -
Development of Halogenated Pyrazolines as Selective Monoamine Oxidase-B Inhibitors: Deciphering via Molecular Dynamics Approach
por: Nair, Aathira Sujathan, et al.
Publicado: (2021) -
Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders
por: Mathew, Bijo, et al.
Publicado: (2021)